For eligible adults with clinically significant obesity, MHRA-approved options include semaglutide (Wegovy, assessed in NICE TA875) and tirzepatide (Mounjaro, assessed in NICE TA1026), both available through NHS pathways with appropriate clinical oversight
we help you manage potential side effects and monitor your progress
Apr 2014;104(1):53-62
How DSIP Works in Your Brain and Body Understanding how DSIP produces its effects requires looking at several interconnected systems in your body
Resources 1 Pelton, Ross, RPh, PhD, CCN, LaValle, James, RPh, DHM,, NMD, CCN, Hawkins, Ernest, RPh, MS, Krinsky, Daniel, RPh, MS